CCND1 and cancer: Interestingly, exogenous MG53 expression could dose-dependently repress the proliferation of cancer cells with relatively abundant cyclin D1 protein (Fig. 2f, g), but had very limited effects on cells with little cyclin D1 (Fig. 2f, h).